Albert Robichaud Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Albert Robichaud.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Albert Robichaud. Albert Robichaud is Chief Scientific Officer in Sage Therapeutics, Inc. ($SAGE).
Latest Insider Trading Transactions of Albert Robichaud
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 12 2021 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 82.27 | 22,500 | 1,851,075 | 22,500 | |
| Apr 30 2020 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 39.87 | 9,450 | 376,772 | 9,450 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 28.63 | 3,076 | 88,066 | 21,924 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 38.25 | 5,732 | 219,249 | 32,668 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 28.63 | 3,076 | 88,066 | 21,924 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 6,935 | 9,432 | 0 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 38.25 | 5,732 | 219,249 | 32,668 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 64.16 | 25,000 | 1,604,000 | 136,400 | 111.4 K to 136.4 K (+22.44 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 6,935 | 9,432 | 0 | |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 28.63 | 3,076 | 88,066 | 111,400 | 108.3 K to 111.4 K (+2.84 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 64.16 | 25,000 | 1,604,000 | 136,400 | 111.4 K to 136.4 K (+22.44 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 38.25 | 5,732 | 219,249 | 108,324 | 102.6 K to 108.3 K (+5.59 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 28.63 | 3,076 | 88,066 | 111,400 | 108.3 K to 111.4 K (+2.84 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 6,935 | 9,432 | 102,592 | 95.7 K to 102.6 K (+7.25 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 38.25 | 5,732 | 219,249 | 108,324 | 102.6 K to 108.3 K (+5.59 %) |
| Dec 10 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 6,935 | 9,432 | 102,592 | 95.7 K to 102.6 K (+7.25 %) |
| Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Payment of Exercise | F | 161.38 | 548 | 88,436 | 95,657 | 96.2 K to 95.7 K (-0.57 %) |
| Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Grant | A | 0.00 | 1,900 | 0 | 96,205 | 94.3 K to 96.2 K (+2.01 %) |
| Jul 29 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 825 | 0 | 94,137 | 95 K to 94.1 K (-0.87 %) |
| Jun 25 2019 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 13,200 | |
| Dec 11 2018 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 6,600 | 314,820 | 6,600 | |
| Apr 04 2018 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 145.77 | 31,500 | 4,591,755 | 31,500 | |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 163.93 | 1,021 | 167,373 | 94,259 | 95.3 K to 94.3 K (-1.07 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 162.21 | 700 | 113,547 | 95,280 | 96 K to 95.3 K (-0.73 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 161.40 | 6,187 | 998,582 | 95,980 | 102.2 K to 96 K (-6.06 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 160.12 | 21,410 | 3,428,169 | 102,167 | 123.6 K to 102.2 K (-17.33 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 159.46 | 8,734 | 1,392,724 | 123,577 | 132.3 K to 123.6 K (-6.60 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 158.18 | 16,748 | 2,649,199 | 132,311 | 149.1 K to 132.3 K (-11.24 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 157.27 | 3,700 | 581,899 | 149,059 | 152.8 K to 149.1 K (-2.42 %) |
| Dec 14 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 156.31 | 1,500 | 234,465 | 152,759 | 154.3 K to 152.8 K (-0.97 %) |
| Feb 08 2017 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 47.70 | 40,000 | 1,908,000 | 40,000 | |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 38.25 | 10,800 | 413,100 | 51,000 | |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,259 | 154.5 K to 154.3 K (-0.16 %) |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,509 | 154.8 K to 154.5 K (-0.16 %) |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 154,759 | 155 K to 154.8 K (-0.16 %) |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 155,009 | 155.3 K to 155 K (-0.16 %) |
| Dec 16 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Gift | G | 0.00 | 250 | 0 | 155,259 | 155.5 K to 155.3 K (-0.16 %) |
| Nov 01 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | M | 1.36 | 15,287 | 20,790 | 6,935 | |
| Nov 01 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | M | 1.36 | 15,287 | 20,790 | 155,509 | 140.2 K to 155.5 K (+10.90 %) |
| Jul 14 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 40.00 | 22,000 | 880,000 | 140,222 | 162.2 K to 140.2 K (-13.56 %) |
| Feb 10 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 28.63 | 25,000 | 715,750 | 25,000 | |
| Jan 26 2016 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 40.02 | 20,000 | 800,400 | 162,222 | 182.2 K to 162.2 K (-10.98 %) |
| Aug 04 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 67.06 | 12,000 | 804,720 | 182,222 | 194.2 K to 182.2 K (-6.18 %) |
| Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 70.62 | 1,757 | 124,079 | 194,222 | 196 K to 194.2 K (-0.90 %) |
| Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.43 | 4,905 | 350,364 | 195,979 | 200.9 K to 196 K (-2.44 %) |
| Jul 01 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 72.79 | 9,338 | 679,713 | 200,884 | 210.2 K to 200.9 K (-4.44 %) |
| Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.21 | 200 | 14,241 | 210,222 | 210.4 K to 210.2 K (-0.10 %) |
| Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 71.67 | 5,231 | 374,909 | 210,422 | 215.7 K to 210.4 K (-2.43 %) |
| Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 72.93 | 5,624 | 410,181 | 215,653 | 221.3 K to 215.7 K (-2.54 %) |
| Jun 02 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Sell | S | 73.89 | 4,945 | 365,403 | 221,277 | 226.2 K to 221.3 K (-2.19 %) |
| Jan 27 2015 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Option Exercise | A | 38.25 | 51,000 | 1,950,750 | 51,000 | |
| Jul 23 2014 | SAGE | Sage Therapeutics, ... | Robichaud Albert | Chief Scientific Of ... | Buy | P | 18.00 | 4,000 | 72,000 | 226,222 | 222.2 K to 226.2 K (+1.80 %) |
Page: 1